Phase I – Other

1,064 trials 249 recruiting

Filter these 1,064 trials by condition, country, sponsor and more.

Open in Search →

A Phase 1, Open-Label, Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid Neoplasms Recruiting

2023-506145-38-00 Treatment of participants with MF, MDS, ET, or MDS/MPN 2021-05-11
Long-Term Follow-Up (LTFU) of Participants Treated with Adoptive Cell Therapies Recruiting

2024-513033-21-00 Non-small cell lung cancer (NSCLC) 2020-09-14
Evaluation of the Pharmacokinetics and Safety of Upadacitinib in Pediatric Subjects with Polyarticular Course Juvenile Idiopathic Arthritis … Recruiting

2023-505060-11-00 Polyarticular Course Juvenile Idiopathic Arthritis 2019-06-19
Study to Learn How Safe EV25 is and the Amount of EV25 in the Body Over a Period of Time, When Given as a Single Dose to Adult Healthy Peopl… Recruiting

2026-525176-26-00 Influenza 2026-05-28
Study of diclofenac skin reservoir formation and emptying after Voltaren Emulgel 2.32% application in healthy participants Recruiting

2025-524764-38-00 For the local, symptomatic treatment of pain in acute b 2026-05-26
Multiple Dose Study of RO7795068 and its effect on Gastric Emptying, and on PK of Oral Contraceptives Recruiting

2025-524052-58-00 Healthy Overweight or Obese 2026-05-21
A Single-Dose Pharmacokinetic Study of Eloralintide in Participants with Varying Degrees of Liver Impairment and Participants with Normal Li… Recruiting

2025-523847-36-00 Participants with Mild, Moderate, or Severe Hepatic Imp 2026-05-19
PHARMACOKINETICS OF PETRELINTIDE FOLLOWING ADMINISTRATION TO PARTICIPANTS WITH IMPAIRED HEPATIC FUNCTION Recruiting

2025-523641-10-00 Healthy / hepatic impaired volunteers only study to ass 2026-05-18
A study to learn more about the safety and effects of a new blood-thinning medicine, given alone and together with another blood-thinner, in… Recruiting

2025-524043-12-00 atrial fibrillation 2026-05-13
A research study looking into blood levels of the medicine NNC0487 0111 in the body and how well it is tolerated in people with reduced live… Recruiting

2025-521647-20-00 hepatic impairment 2026-05-12
A study to investigate the safety, tolerability, pharmacokinetics, immunogenicity and pharmacodynamics of a single subcutaneous dose of GSK4… Recruiting

2025-525073-37-00 Autosomal Dominant Polycystic Kidney Disease 2026-05-12
A randomised, open-label, single-centre, drug-drug-interaction trial to evaluate the impact of carboxylesterase 2 (CES2)- and CYP3A4-inhibit… Recruiting

2026-526135-18-00 Idiopathic pulmonary fibrosis 2026-05-12
Effect of NBI-921355 on corticospinal excitability in healthy participants Recruiting

2025-524134-26-00 Epilepsy 2026-05-08
Allogeneic adipose tissue derived-stem cells in Alzheimer disease Recruiting

2022-502846-28-00 Alzheimer 2026-05-07
Pilot, randomized, crossover, comparative bioavailability study of two tadalafil formulations (oral suspension and film-coated tablets) afte… Recruiting

2026-525930-47-00 Healthy volunteers 2026-05-07
GRT-1C102: A randomized, double-blind, placebo-controlled dose escalation study to evaluate the safety, tolerability, and pharmacokinetics/p… Recruiting

2025-524328-24-00 Ulcerative colitis 2026-05-06
A study to learn about the amount of asundexian in the blood and the effect of food on its levels when healthy participants take it as adult… Recruiting

2025-523677-41-00 Prevention of thromboembolic events 2026-05-06
A Phase 1b, Double-Blind Study to Investigate Safety, Tolerability, Pharmacokinetics, Efficacy, and Pharmacodynamics of Single Dose of ATI-0… Recruiting

2025-524987-39-00 Mild to Moderate Asthma 2026-05-04
A PHASE 1, OPEN-LABEL, SINGLE-DOSE MASS BALANCE AND METABOLITE PROFILING STUDY OF 14C-LABELED IZICOPAN (INF904) IN HEALTHY MALE PARTICIPANTS Recruiting

2026-525517-31-00 Not applicable, healthy volunteers 2026-05-04
A study in people with advanced cancer to test how well different doses of BI 3819026 are tolerated when taken alone and together with ezabe… Recruiting

2025-522953-21-00 unresectable advanced or metastatic solid cancer 2026-04-30
A clinical trial of MK-6050 in healthy participants (MK-6050-002) Recruiting

2026-525625-21-00 Hidradenitis suppurativa 2026-04-28
A Phase 1 Study to Assess Radiation Biodistribution, Dosimetry, Pharmacokinetics and Safety of GEH300079 (68Ga) Injection and Determine the … Recruiting

2025-522541-21-00 Peritoneal Carcinomatosis of Colorectal,Gastric, Pancre 2026-04-28
A research study looking into how cagrilintide influences food intake and appetite in people with overweight or obesity Recruiting

2025-524206-15-00 Obesity 2026-04-24
An early Phase 1b Study to assess how safe and effective is the treatment with drugs, called Mosunetuzumab or Glofitamab in Combination with… Recruiting

2023-505185-28-00 Non-Hodgkin Lymphoma 2026-04-23